Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Mark Cutler

1PUBLICATIONS

10CO-AUTHORS

Infant and child health

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Jan 30, 2025

A Phase 3B, Open-Label Study to Evaluate the Immunogenicity and Safety of the Quadrivalent Meningococcal Nimenrix<sup>®</sup> Vaccine When Given to Healthy Infants at 3 and 12 Months of Age.

Susanna Koski, Federico Martinon-Torres, Mika Rämet

Pageof 1

Frequent Collaborators

1 joint publications

Susanna Koski

1 joint publications

Federico Martinon-Torres

1 joint publications

Mika Rämet

1 joint publications

Paula Peyrani

1 joint publications

Jamie Findlow

1 joint publications

Paul Balmer

1 joint publications

Luis Jodar

1 joint publications

William C Gruber

1 joint publications

Annaliesa S Anderson

1 joint publications

Johannes Beeslaar

Frequent Collaborators

1 joint publications

Susanna Koski

1 joint publications

Federico Martinon-Torres

1 joint publications

Mika Rämet

1 joint publications

Paula Peyrani

Top Related Videos

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant <em>Staphylococcus aureus</em> (MRSA) Infection

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant <em>Staphylococcus aureus</em> (MRSA) Infection

Published on : Sep 01, 2023

See more related videos

Top Related Videos

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant <em>Staphylococcus aureus</em> (MRSA) Infection

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant <em>Staphylococcus aureus</em> (MRSA) Infection

Published on : Sep 01, 2023

See more related videos